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The stromal progenitors of mesodermal cells, mesenchymal stromal cells (MSCs), are a heterogeneous population of plastic
adherent fibroblast-like cells with extensive proliferative capacity and differentiation potential. Human MSCs have now been
isolated from various tissues including bone marrow, muscle, skin, and adipose tissue, the latter being one of the most suitable cell
sources for cell therapy, because of its easy accessibility, minimalmorbidity, and abundance of cells. Bonemarrow and subcutaneous
or visceral adipose tissue samples were collected, digested with collagenase if needed, and seeded in Iscove’s medium containing
5% human platelet lysate. Nonadherent cells were removed after 2-3 days and the medium was replaced twice a week. Confluent
adherent cells were detached, expanded, and analyzed for several biological properties such as morphology, immunophenotype,
growth rate, senescence, clonogenicity, differentiation capacity, immunosuppression, and secretion of angiogenic factors.The results
show significant differences between lines derived from subcutaneous fat compared to those derived from visceral fat, such as the
higher proliferation rate of the first and the strong induction of angiogenesis of the latter. We are convinced that the identification
of the peculiarities of MSCs isolated from different tissues will lead to their more accurate use in cell therapy.
1. Introduction
By definition mesenchyme is an embryonic tissue consisting
of loosely packed, unspecialized cells set in a gelatinous
ground substance, from which connective tissue, bone, car-
tilage, and the circulatory and lymphatic systems develop.
Indeed, mesenchymal multipotent stromal cells (MSCs) have
been shown to reside within the connective tissue of the
most organs. In particular, the first and most rich source
for isolation of MSCs has been the bone marrow (BM) of
different adult organisms. These cells were initially char-
acterized as plastic adherent, fibroblastic-shaped, with a
multipotency differentiation capacity both in vitro and in
vivo. In 2006 the International Society for Cellular Therapy
(ISCT) has suggested a number of phenotypic and functional
characteristics to identify mesenchymal stem cells including
coexpression of several CD antigens and differentiation into
multiple connective tissue cell types such as chondrocytes,
adipocytes, and osteocytes [1]. Since then and because of
their plasticity, BM-derived MSCs represent an attractive
source for cell therapy applications and for studying the
mechanism of tissue regeneration. The discovery that the
nonadipocyte, stromal fraction of adipose tissues (ATs) con-
tains an abundant population of multipotent progenitors has
identified a novel source of cells for therapeutic use. Indeed,
both subcutaneous and visceral adipose tissue could be easily
collected from different sites during clinical practice in a
minimally invasive procedure. AT-derivedMSCs are ideal for
cellular therapy applications because they can be harvested,
multiplied, and handled easily, efficiently, and noninvasively.
Moreover morbidity to donors is considerably less, requiring
only local anesthesia and exhibiting a short wound healing
time [2].
Although the physical contribution of resident MSCs to
tissue regeneration is still on debate, it has been clearly shown
that implanted MSCs promote tissue repair by secreting
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factors that enhance proliferation of endogenous progenitors,
decrease inflammatory response, and favor the angiogenesis
process [3]. Nevertheless, BM-, AT-, and umbilical cord
blood-derived MSC showed characteristic gene expression
signatures [4], thus suggesting that, despite the criteria
proposed by ISCT for MSC characterization [1], the various
cell lines possess different biological properties.
Then, sinceMSCs are a sure promise for the future of stem
cell-based therapeutic strategies, it would be necessary to
identify the characteristics of each cell line in order to use the
one that best responds to the specific treatment requirement.
Following this idea, we characterized some biological
properties of mesenchymal cells isolated from subcutaneous
and visceral adipose tissues. Their comparison with the “gold
standard” BM-derived MSCs and with a common fibroblast
cell line has evidenced the peculiarities that distinguish and
characterize AT-derived MSCs.
2. Materials and Methods
2.1. Platelet Lysate Preparation. Platelet lysate pool (PLP) was
obtained from the discarded buffy coat fractions (BC) after
automatic separation of red blood cells and plasma. Briefly
the BC of 15–20 homologous volunteer donors was pooled,
diluted in 100–200mL ABO compatible plasma with heparin
(40U/mL), and centrifuged (340 g, 6min, 22∘C) to obtain
the platelet-rich plasma (PRP). The PRP was adjusted, with
plasma, at a platelet concentration of 1.2 ± 0.4 × 106/𝜇L,
frozen at −80∘C for 24–72 h, and thawed at 37 ∘C for 10 min
to lyse the platelets. After a second centrifugation (4000 g,
15min, 22∘C) aimed to remove platelet bodies or debris, the
PLP obtained was aliquoted and stored at −25–30∘C [5–7].
2.2. Cell Culture. Bone-marrow-derived MSCs were obtain-
ed from bag washouts after scheduled bone marrow har-
vests according to standards of National Marrow Donor
Program. Total nucleated cells from filter and bag residues
were obtained after two washings with 100–150mL PBS
and centrifugation at 200 g for 10min. The pellet material
was gently resuspended in 20–30mL PBS and separated
by Ficoll-Hypaque gradients centrifugation (Lympholyte-H,
Biosera) to yield mononuclear cells. The mononuclear cells
were cultured in 25 cm2 culture flasks until they reached
confluence and were defined passage 0. Subsequent passages
were seeded at 4000 cells/cm2.
Cells were grown in Iscove’s medium (Sigma) contain-
ing Penicillin (100U/mL)/Streptomycin (100 𝜇g/mL) (P/S),
200mM L-glutamine, 25 𝜇g/mL fungizone, and 5% PLP
(MSC medium).
Adipose-derived MSCs were isolated from visceral (O-
MSC, omental) or subcutaneous (L-MSC, lipoaspirate) adi-
pose tissues of different donors (middle age). Omental
samples (25–30 g) were transferred in sterile PBS, repeatedly
washed to remove blood residuals, minced with scissors and
scalpels, centrifuged to remove liquid phase, and digested
with 0,075% collagenase IA (Sigma) at 37∘C for 40–50min.
Enzyme activity was neutralized by addition of Iscove’s
medium (Sigma) containing 20% fetal bovine serum (FBS,
Biosera). Lipoaspirates were diluted in PBS and the fat
phase digested as above. Dispersed cells were centrifuged
10min at 1200 g, resuspended in Iscove’s medium containing
P/S, 200mM L-glutamine, 25 𝜇g/mL fungizone, 5% PLP,
filtered (100 𝜇m) to remove undigested tissue, and plated at
50,000 cells/cm2 in 75 cm2 culture flasks. Subcultures were
seeded at 2,000 cells/cm2 [8].
Human foreskin fibroblasts (HFFs) were provided by
ATCC (Number: CRL-2429) and were grown in DMEM
(Sigma), 10% FBS.
2.2.1. Growth Kinetics. For the assessment of growth kinetics
MSCs at P4 and HFF were seeded at 2 × 103 cells/cm2 in
24-well plate. Every day, over 2 weeks, cells from three
pooled wells were trypsinized, resuspended in PBS con-
taining 5% FBS in TRUCOUNT tubes (BD Biosciences),
and analyzed with flow cytometer (FACSCanto Diva, BD
Bioscience). Viability was assessed by addition of 7-amino-
actinomycin D (7-AAD, BD Biosciences). Population dou-
bling time (h) was calculated using the algorithm provided
by http://www.doubling-time.com/.
2.2.2. Senescence Assay. Cells were seeded at 5× 104 cells/cm2
in 24-well plate and incubated in standard conditions. After
2 days, cells were fixed with 1% glutaraldehyde solution for
5min and the 𝛽-galactosidase (𝛽-gal) enzymatic activity at
pH 6.0, that excludes the lysosomal isoform, was visualized
by staining cells with the chromogenic substrate 5-bromo-4-
chloro-3 indolyl-𝛽-d-galactopyranoside (X-gal).The number
of 𝛽-gal positive cells in three randommicroscopic fields was
evaluated.
2.2.3. Immunophenotypic Analysis. BM-MSC, L-MSC, O-
MSC, and HFF were trypsinized and resuspended in flow
cytometry buffer (PBS pH 7.2, FBS 2%, sodium azide 0.01%).
Single cell suspensions (5 × 105 cells/100 𝜇L) were incubated
20min with the conjugated monoclonal or isotype-matched
IgG control antibodies. After extensive washes, cells were
analyzed by flow cytometry. Cellular viability was assessed
by incubating cell suspension with plasma membrane per-
meability marker 7-amino-actinomycin D (7-AAD, BD Bio-
science). CD45 Pe-Cy7, CD73 PE, CD90 FITC, CD105 PerCP-
Cy5.5, CD31 PE, and CD34 APC, were from BD Biosciences.
CD146 PerCP-Cy5.5 and CD105 FITC were from Biolegend,
CD133 APC was from Miltenyi Biotec, and anti SSEA4-PE
was from R&D.
2.3. Cell Differentiation. Cell differentiation was achieved
using StemPro Adipogenesis, Osteogenesis, and Chondro-
genesis differentiation kits (Life technologies), following the
manufacturer’s instruction. At the end of the differentiation
period, all cultures were fixed with 4% formaldehyde for
30min and adipocytes stained with 0,3% Oil Red O solution
for 10min; bone cells with 2% Alizarin Red S solution (pH
4.2) for 3min, while micromass cultures of chondrocytes
were stained with 1% Alcian blue solution in 0.1 N HCl for
30 minutes.
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Table 1: Flow cytometry characterization of MSC populations.
Cell
population
Passage
number
CD45
(%)
CD105
(%)
CD90
(%)
CD73
(%)
CD146
(%)
CD133
(%)
CD34
(%)
CD31
(%)
MSC
(%)
EPC
(%)
EC
(%)
L-MSC 0 1.5 96 97 98 91 0.5 1.7 2.4 95 0.3 2.5
3 0.1 95 98 97 93 0.3 0.3 0.3 95 <0.1 0.7
O-MSC 0 18 74 86 90 72 0.4 2.3 2.8 64 <0.1 <0.1
3 0 83 92 89 98 0.1 3.1 0.9 80 <0.1 <0.1
BM-MSC 0 8 93 95 96 94 1.1 3.5 0.5 94 0 <0.1
3 4 98 98 99 93 0.8 0.2 0.3 98 0 0
HFF u.d. 0 100 100 100 31 0 n.d. 0 100 0 0
MSCs were defined by coexpression of CD105, CD90, and CD73; EPC were defined by coexpression of CD133, CD146, CD105, and CD31; and EC were defined
by coexpression of CD34, CD146, CD105, and CD31. The reported values represent intensity mean of two independent experiments. u.d.: undefined; n.d.: not
determined.
2.4. RNA Extraction, Semiquantitative and Quantitative RT-
PCR Analysis. Total RNA was extracted from MSC as des-
cribed [9]. Contaminating DNA was digested using DNAse,
following indications reported in RNeasy Micro Handbook
(Qiagen). Two 𝜇g of total RNA were retrotranscribed with
MMLV reverse transcriptase (InVitrogen) using random
hexaprimers in a final 20𝜇L volume. Quantitative PCR
(qPCR) was performed with a Biorad iCycler iQ Real-Time
PCR Detection System using a iQ SYBR Green Supermix
(Biorad) according to the manufacturer’s instructions. The
qPCR specific primers (final concentration 400 nM) were as
follows: GAPDH for: 5󸀠-GAAGGTCGGAGTCAACGGATT;
rev: 5󸀠-TGACGGTGCCATGGAATTTG; Oct4 for: 5󸀠-GGG-
TTTTTGGGATTAAGTTCTTCA; rev: 5󸀠-GCCCCCACC-
CTTTGTGTT; Nanog for: 5󸀠-AGGAAGACAAGGTCC-
CGGTCAA; rev: 5󸀠-TCTGGAACCAGGTCTTCACCTGT;
Sox2 for: 5󸀠-CAAAAATGGCCATGCAGGTT; rev: 5󸀠-AGT-
TGGGATCGAACAAAAGCTATT; Klf4 for: 5󸀠-AGCCTA-
AATGATGGTGCTTGGT; rev: 5󸀠-TTGAAAACTTTG-
GCTTCCTTGTT. Gene expression levels were evaluated
using BM-MSC as reference cell line. Data were analyzed
using REST [10].
2.5. Immunosuppression Assay. Peripheral blood mononu-
clear cells (PBMCs) were isolated from the blood of healthy
donors by Ficoll gradient, resuspended in RPMI 1640 (Sigma)
supplemented with 10% FBS, Penicillin (100U/mL)/Strep-
tomycin (100 𝜇g/mL) (P/S), 200mM L-glutamine, 25 𝜇g/mL
fungizone, and labeled with the vital dye carboxyfluores-
cein diacetate, succinimidyl ester (CFSE, 0,8 𝜇M, Sigma)
for 20min at 37∘C. Then, 2 × 105 CFSE-loaded cells were
seeded on irradiated (30Gy) MSC or HFF plated at 2.5 ×
104 cell/well in U bottom 96-well plate. PBMC proliferation
was stimulated by addition of 5𝜇g/mL phytohemagglutinin
(Sigma) for 5 days. The serial halving of the fluorescence
intensity of CFSE, that corresponds to cell division, was
evaluated by flow cytometry [11]. Data were analyzed with
FlowJo program.
2.6. Endothelial Cell Sprouting Assay. Human umbilical vein
endothelial cells (HUVECs) have been aggregated as
spheroid bodies inM199 (Sigma) culture medium containing
10% FBS and 20% methylcellulose (Sigma), in a round
bottom 96-well plate, 1000 cells/well. Under these conditions
all suspended cells contribute to the formation of a single
endothelial cell spheroid. After 18–24 h the HUVEC
spheroids (20 spheroids/sample) were embedded into
collagen gel (Roche) and incubated at 37∘C to polymerize for
1 h.The layer of collagen gel/spheroids has been covered with
culture medium containing conditionedmedium (CM) from
the various cell lines.The number of sprouts per spheroid was
analyzed using ImageJ software (http://rsb.info.nih.gov/ij/)
and compared with those induced by VEGF (30 ng/mL). At
least two replicates were included within each experiment.
CM was obtained by seeding cells at 2.6 × 104 cells/cm2
and incubating cultures for 48 h in standard conditions. CMs
were collected, clarified by centrifugation, concentrated using
3000KCentricon (Millipore), and stored at−80∘Cuntil used.
3. Results
3.1. MSC Isolation and Characterization. Recently, adipose
tissue (AT) has been proposed as a source of therapeutic
stromal cells with functional characteristics overlapped to
that of BM-derived MSC; indeed, the large number of cells
isolated from AT and their higher proliferation rate early
responds to the request of cells to be used for therapeutic
purposes. To address some of the open questions concerning
the biological properties of these cells, we isolated adipose-
derived mesenchymal stromal cells from surgical lipoaspi-
rates (L-MSC) or from omentum (O-MSC) by collagenase
digestion of the tissue, while BM-MSCs were obtained from
bag washouts after scheduled bone marrow harvest. MSCs
within the samples were allowed to adhere to a cell culture
dish and maintained in culture for several passages, using
a PLP-containing medium. Once cell lines were established,
the different MSC populations were characterized following
the criteria suggested by the International Society for Cel-
lular Therapy [1]. Flow cytometry was used to assess cell
viability (7AAD exclusion) and to evaluate the percentage
of cultured cells that do not belong to the hematopoi-
etic lineage (CD45−), but coexpress MSC antigens CD105,
CD90, and CD73 (Table 1). Since endothelial cells share
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Table 2: Proliferation properties of MSC.
Cell Population Doubling time (h) Density at confluence Cell senescence Clones (limiting dilution) Clones (CFU)
L-MSC 18.76 140,000 15.2% 1.44% 9%
O-MSC 34.03 44,000 11.45% 0.66% 0%
BM-MSC 35.07 50,000 30.00% 0.22% 12%
HFF 17.06 >200,000 4.63% 0.00% >50%
The reported values represent the mean of two independent experiments.
some of the MSC markers, the presence of both precur-
sor (CD133+/CD105+/CD146+/CD31+/CD45−) and mature
(CD34+/CD105+/CD146+/CD31+/CD45−) endothelial cells
was evaluated in parallel.The same analysis was repeated later
on and, although the percentage of starting MSC population
was high, it further increases after the first two passages in
culture, ranging from 80% for O-MSC, up to 97% for BM-
MSC (Table 1). Since endothelial cells, both precursors and
mature cells, represent, at higher passage, less than 1% of
the total population, our data point to the uniformity of the
MSCpopulations that has beenmaintained up to P8 (data not
shown).Then, all the following experiments were carried out
using MSC at P4.
3.2. Proliferative Properties of MSC. The possibility to use
MSC as therapeutic agent leads us to culture the cells in a
medium free of animal serum. Indeed, by growing cells in
5% hPLP rather than fetal bovine serum [6], we were able to
expand L-MSC at the fifth passage 15322 times (correspond-
ing to approximately 14 duplications; range 1400–76199) in
respect to the 422 times (corresponding to approximately 9
duplications; range 16–827) of FBS. The proliferation rates
of MSC grown in Iscove’s medium containing 5% hPLP are
shown in Figure 1. Doubling time (DT) calculation of their
logarithmic growth phase (h) indicates that L-MSC grow
faster than O- or BM-MSC (Table 1) and indeed similar
results were shown by other groups [12].
Morphologically all the MSCs have a spindle-shaped
appearance but L-MSCs are more closely related to HFF,
whereas O-MSCs mostly resemble BM-MSC (data not
shown). Because of this morphology, cell number at conflu-
ence is very different, being at least doubled for L-MSC in
respect to O- and BM-MSC (Table 2). Since the lower pro-
liferation rate of O- and BM-MSC could be explained by an
increased cellular aging, we analyzed replicative senescence-
associated cytoplasmic𝛽-galactosidase activity.MSC cultures
were fixed, stained with X-gal, and the number of cells
containing the cyan dye was evaluated. No correlation was
found with cellular senescence and the age of donor. As
shown in Table 1, BM-MSC showed the higher percentage of
senescent cells, doubling the values found in adipose-derived
MSC. Nevertheless, no significant differences were found in
L- andO-MSC, thus excluding the hypothesis of an increased
senescence for the latter.
3.3. Clonal Properties of MSC. By definition stem cells
undergo “unlimited” division because of their self-renewal
capacity. To define the presence of stem cells in our popu-
lations, we analyzed MSC in colony formation and limiting
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Figure 1: Proliferative properties of adipose-derived MSC. Growth
curve of MSC populations at P4 inMSCmedium. Cells were seeded
at 2 × 103 cells/cm2 and counted daily in triplicate in TRUCOUNT
tubes (BD Biosciences), using FACSCanto Diva flow cytometer (BD
Biosciences). Data represent the mean of at least two independent
experiments.
dilution assays. Both tests evaluate the clonal capacity of
a cell but, while in the colony formation assay the cells
(100 cells/10 cm dish) are maintained in a common medium,
in the limiting dilution assay every cell (500 cells in 96-well
plates) must condition its own environment. The results we
obtained are shown in Table 2. In general, the percentage
of clonal cells in MSC populations was low, in agreement
with literature data [13]. In detail, the number of clones
was similar in L- and BM-MSC, while was bending to zero
for O-MSC. It should be pointed out that in the limiting
dilution assay we obtained a lower number of clones, due to
the difficulty of a single cell to survive in an unconditioned
environment. Indeed, HFF cells, which are devoid of any
stemness competence, do not survive in this condition.
3.4. Differentiation Capacity of MSC. Stemness is also asso-
ciated with the capacity of the cells to differentiate into
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Figure 2: Differentiation capacity of adipose-derivedMSC. (a) Cells were detached with trypsin and SSEA4membrane protein was evaluated
by flow cytometry using a PE-conjugated antibody. (b) qPCR analysis of the expression of pluripotency markers in MSC. Total RNA was
extracted from cell lines, equivalent amounts of cDNA were amplified by qPCR and gene expression levels were quantified using REST [10].
BM-MSC was used as a reference cell line. Data are representative of at least two independent experiments. (c) Oil Red O staining of MSC
after adipogenic induction, Alcian Blue staining after chondrogenic induction, and Alizarin Red staining after osteogenic induction.
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Figure 3: Immunosuppressive capacity of adipose-derived MSC. PBMCs were loaded with CFSE (−CNTRL) and stimulated with PHA
(+CNTRL) to induce cell proliferation. CD3 positive cells were evaluated by flow cytometry. Data represent the dilution of CSFE
corresponding to cell division. Percentages represent the amount of resting cells.
several lineages and MSCs are often referred as multipotent
cells, with a differentiation potential restricted tomesodermal
tissues. However, their aptitude, under defined conditions,
to transdifferentiate in cells of ectodermal and endodermal
origin has been also demonstrated [14, 15]. In order to
investigate the differentiation potential of AT-derived MSC,
some of the genes associated with pluripotency have been
evaluated by qPCR and flow cytometry.The results illustrated
in Figure 2(b) show low levels of Oct4 and Nanog in all
MSCs, thus suggesting the absence of pluripotency for these
cell lines. Besides, Sox2 and, mostly, Klf4, a transcriptional
regulator of adipogenesis [16], are selectively upregulated in
AT-derived MSC.
On the other hand, the membrane marker SSEA4 is
characteristic of the entire BM-derived population, while is
expressed by 25% of L-MSC population and only by 8.5% of
O-MSC (Figure 2(a)).
Following these results, we tested the canonical differ-
entiation properties of MSC along the adipogenic, chon-
drogenic, and osteogenic lineages, using StemPro differ-
entiation kits (Life Technologies), together with HFF. The
results (Figure 2(c)) show that all the three cell lines easily
differentiate in adipocytes and chondrocytes as illustrated
by Oil Red O and Alcian Blue staining, respectively. On the
contrary, osteogenesis, represented by Alizarin Red staining
of calcium deposition, was poorly effective in O-MSC, even
with different media (data not shown). A weaker differen-
tiation capacity of the O-MSC in respect to L-MSC is also
reported by Toyoda et al. [17]. Because of these results, and
following ISCT guidelines [1], we cannot classify O-MSC as
mesenchymal stem cells.
3.5. Immunosuppression. The most important property of
mesenchymal stem cells, that allows their therapeutic allo-
genic use in graft versus host disease, is their capacity to
suppress activation of immune cells [18, 19]. Then, PHA-
stimulated PBMCs were challenged with MSC populations
and the cell division of CD3+ cells was monitored by flow
cytometry. The results are shown in Figure 3, where the
percentage represents the number of nondividing resting
cells. Unstimulated cells represent the negative control, while
the positive control is signified by PBMC stimulated with
PHA alone. At variancewith fibroblasts, allMSCpopulations,
including O-MSC, immunosuppress PHA-induced prolifera-
tion of T cells.
3.6. Secretion of Angiogenic Growth Factors. Several papers
report that the benefits derived from MSC injection might
result from the secretion of several factors including those
that stimulate neovascularization of injured tissue [20]. To
assess the angiogenic potential of MSC, we investigated the
capacity of their conditioned medium (CM) to induce the
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Figure 4: In vitro angiogenesis of MSC conditioned medium. 3D collagen-embedded HUVEC spheroids were stimulated with CM from the
reported cell populations. (a) Microscopic observation at 24 h. (b) Representation of modeled counts using a statistic general linear model
with exponential weights. ∗∗∗Significant differences (𝑃 < 0.001).
sprouting of collagen-embedded HUVEC spheroids. Results
are shown in Figure 4. In agreement with literature data, CM
derived from all the MSC populations shows an angiogenic
capacity that in the case of O-MSC can be compared to those
exerted by the proangiogenic protein vascular endothelial
growth factor (VEGF).
4. Discussion
The adipose tissue is made of a large number of adipocytes
and other nonfat cells, surrounded by connective tis-
sue matrix. The nonadipocyte cellular components include
inflammatory cells, immune cells, preadipocytes, and fibrob-
lasts, together with endothelial cells and pericytes which
constitute the capillary network [21]. Then, one or more of
these cell types must be the source of cultured mesenchymal
stem/stromal cells. From recent literature, it has been sug-
gested that blood vessels harbor perivascular native ancestors
of the cultured MSC and, depending on the anatomy of the
vessel, can be classified as pericyte- or adventitial-derived
MSC [22]. Although the International Society for Cellular
Therapy (ISCT) has suggested a number of phenotypic
and functional characteristics to identify mesenchymal stem
cells, an updated classification, following recent literature, is
urgently needed. Indeed, the cluster of differentiation (CD)
markers we analyzed (CD105, CD90, CD73) are coexpressed
by all the mesenchymal-derived cells, including endothelial
cells, fibroblasts, and pericytes, thus making this evaluation
redundant. In this regard, our data confirm the specificity of
CD31, Pecam-1, as a true endothelial cell marker.
In our study, we have considered adipose tissue samples
derived from subcutaneous and visceral fat, obtained
respectively by lipoaspiration and from omentum. Although
other groups have compared AT-MSC from different sources,
parallel controls with BM-MSC or fibroblasts were missing.
Because of the lack of cell identification markers, it is of
outmost importance to refer the results to what is considered
a “gold-standard” (BM-MSC) and to extensively describe the
biological characteristics of the selected stromal cells.
The application of ISCT guidelines to our cells implies
that lonely L-MSC can be ranked as mesenchymal stem cells,
because O-MSC, even though we tested different media, lack
the capacity to differentiate toward the osteogenic lineage.
A weaker differentiation capacity of the omental-derived
MSC is also reported by Toyoda et al. [17], although in
both cases the samples do not belong to the same patient.
Nevertheless, these omental cells, that share all the other
properties with the so-called stem cells, hold the highest
angiogenic potential, as also shown by other groups [23, 24].
Then, from a therapeutic point of view, these cells could
be useful in pathologies where cellular differentiation is not
required but both immunosuppression and a proangiogenic
environment are needed. From the various studies, a number
of subpopulations of mesenchymal cells are emerging for
which it is absolutely necessary to identify unique markers
suitable for their isolation and characterization. In this
regard, as reported for mice [25], we showed that also in
humans SSEA4 expression is elevated in BM-MSC, but,
unfortunately, is expressed also by fibroblasts, thus limiting
its effectiveness as a specific cellular marker.
In conclusion, our data showed that cells CD105+/CD90+/
CD73+/CD45− isolated from subcutaneous or from omental
adipose tissues possess distinct characteristics. In particular,
L-MSCs hold the biological and therapeutical properties of
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BM-MSC, such as the multipotent differentiation capacity
and the immunosuppressive capability, but, in addition, have
a higher proliferation rate. On the other hand, the omental
cells, even if devoid of osteogenic differentiation, are also
able to suppress T cell proliferation and, even better, possess
the highest proangiogenic capacity.These properties propose
L-MSC as a valuable therapeutic substitute of BM-MSC
and identify O-MSC as the cells responsible for the widely
recognized tissue healing properties of the omentum.
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